Pharmaceutical News and Articles

Moms Take on 70% of 'Mental Load' for Household Tasks: Study

If you re a mom right now, you are likely tearing your hair out as you juggle the sizable scheduling demands of the holiday season. Maybe you feel like you are

U.S. FDA Approves Pfizer’s Braftovi Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer

Sumitomo Pharma America Announces U.S. FDA Approval of Gemtesa (vibegron) for Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia

Tevimbra Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy

Vertex Announces U.S. FDA Approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del Trikafta-Responsive Variants

How to Manage the Blues this Holiday Season

watch a favorite classic movie, make a family dish or continue a family tradition that they loved.6. Expand your idea of self-care. It s not just about bubble b

LimmaTech Awarded FDA Fast Track Designation for Vaccine Candidate Against Staphylococcus aureus

December 19, 2024 LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today

New Legislation Will Help Schools Handle Heart Emergencies

Schoolkids will be better able to save the life of a cardiac arrest victim, thanks to a new law signed this week by President Joe Biden.The Cardiomyopathy Healt

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

Vertex Pharmaceuticals Incorporated (Nasdaq VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1

FDA Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Subcutaneous Injection for Use in Most Previously Approved Solid Tumor Opdivo (nivolumab) Indications